Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vinay Kumar Rathi, M.D.

Concepts

Back to Details
This page shows the publications Vinay Rathi has written about Cross-Sectional Studies.
Vinay Rathi
Connection Strength
0.714
Cross-Sectional Studies
  1. Compensation Rates for Otolaryngologic Procedures Under the Medicare Physician Fee Schedule in 2018. Laryngoscope. 2021 06; 131(6):E1785-E1791.
    View in: PubMed
    Score: 0.053
  2. Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019. JAMA Intern Med. 2020 12 01; 180(12):1701-1703.
    View in: PubMed
    Score: 0.053
  3. Price Transparency for COVID-19 Testing Among Top US Hospitals. J Gen Intern Med. 2021 01; 36(1):245-247.
    View in: PubMed
    Score: 0.052
  4. CARES Act Provider Relief Fund Aid to Otolaryngologists in Small Practices. Otolaryngol Head Neck Surg. 2021 03; 164(3):542-544.
    View in: PubMed
    Score: 0.052
  5. Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011. JAMA Netw Open. 2020 08 03; 3(8):e2014496.
    View in: PubMed
    Score: 0.051
  6. Analysis of Venture Capital Investment in Therapeutic Otolaryngologic Devices, 2008-2017. JAMA Otolaryngol Head Neck Surg. 2019 Apr 01; 145(4):387-389.
    View in: PubMed
    Score: 0.047
  7. US Food and Drug Administration Clearance of Moderate-Risk Otolaryngologic Devices via the 510(k) Process, 1997-2016. Otolaryngol Head Neck Surg. 2017 10; 157(4):608-617.
    View in: PubMed
    Score: 0.042
  8. Industry Sponsorship of Research in Otolaryngology: An Examination of the Centers for Medicare & Medicaid Services Open Payments Database. JAMA Otolaryngol Head Neck Surg. 2017 08 01; 143(8):842-843.
    View in: PubMed
    Score: 0.042
  9. Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014. Otolaryngol Head Neck Surg. 2017 04; 156(4):683-692.
    View in: PubMed
    Score: 0.040
  10. Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High-Risk Otolaryngologic Devices, 2000-2014. Otolaryngol Head Neck Surg. 2017 02; 156(2):285-288.
    View in: PubMed
    Score: 0.040
  11. Industry ties in otolaryngology: initial insights from the physician payment sunshine act. Otolaryngol Head Neck Surg. 2015 Jun; 152(6):993-9.
    View in: PubMed
    Score: 0.035
  12. Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey. Trials. 2014 Oct 02; 15:384.
    View in: PubMed
    Score: 0.034
  13. Sharing of clinical trial data among trialists: a cross sectional survey. BMJ. 2012 Nov 20; 345:e7570.
    View in: PubMed
    Score: 0.030
  14. Markup on Services Provided to Medicare Beneficiaries by Otolaryngologists in 2017: Implications for Surprise Billing. Otolaryngol Head Neck Surg. 2021 11; 165(5):662-666.
    View in: PubMed
    Score: 0.013
  15. Telemedicine Services Provided to Medicare Beneficiaries by Otolaryngologists Between 2010 and 2018. JAMA Otolaryngol Head Neck Surg. 2020 Sep 01; 146(9):816-821.
    View in: PubMed
    Score: 0.013
  16. Assessment of Gender Differences in Clinical Productivity and Medicare Payments Among Otolaryngologists in 2017. JAMA Otolaryngol Head Neck Surg. 2020 09 01; 146(9):1-10.
    View in: PubMed
    Score: 0.013
  17. Otolaryngologist Performance in the Merit-Based Incentive Payment System in 2017. JAMA Otolaryngol Head Neck Surg. 2020 07 01; 146(7):639-646.
    View in: PubMed
    Score: 0.013
  18. Trends in Ambulatory Surgery Center Utilization for Otolaryngologic Procedures among Medicare Beneficiaries, 2010-2017. Otolaryngol Head Neck Surg. 2020 Jun; 162(6):873-880.
    View in: PubMed
    Score: 0.013
  19. State-Sponsored Price Transparency Initiatives for Otolaryngologic Procedures in 2019. JAMA Otolaryngol Head Neck Surg. 2020 04 01; 146(4):378-380.
    View in: PubMed
    Score: 0.013
  20. Financial Implications of Site-Neutral Payments for Clinic Visits in Otolaryngology. JAMA Otolaryngol Head Neck Surg. 2020 01 01; 146(1):78-79.
    View in: PubMed
    Score: 0.012
  21. Female Authorship of Opinion Pieces in Leading Otolaryngology Journals between 2013 and 2018. Otolaryngol Head Neck Surg. 2020 01; 162(1):35-37.
    View in: PubMed
    Score: 0.012
  22. Analysis of Potential Conflicts of Interest among Otolaryngologic Patient Advocacy Organizations in 2016. Otolaryngol Head Neck Surg. 2019 12; 161(6):967-969.
    View in: PubMed
    Score: 0.012
  23. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015. Ophthalmology. 2017 08; 124(8):1237-1246.
    View in: PubMed
    Score: 0.010
  24. Publication of Clinical Studies Supporting FDA Premarket Approval for High-Risk Cardiovascular Devices Between 2011 and 2013: A Cross-sectional Study. JAMA Intern Med. 2016 Apr; 176(4):551-2.
    View in: PubMed
    Score: 0.010
  25. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval? Clin Orthop Relat Res. 2016 Apr; 474(4):1053-68.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.